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Abstract
Background: Intimate partner violence (IPV) is prevalent among adolescent and adult women, with significant
physical, sexual, and mental health consequences. In 2011, the Institute of Medicine’s Clinical Preventive Services for
Women consensus report recommended universal screening for violence as a component of women’s preventive
services; this policy has been adopted by the Health Resources and Services Administration (HRSA). These policy
developments require that effective clinic-based interventions be identified, easily implemented, and taken to scale.
Methods: To foster dialogue about implementing effective interventions, we convened a symposium entitled
‘‘Responding to Violence Against Women: Emerging Evidence, Implementation Science, and Innovative Inter-
ventions,’’ on May 21, 2012. Drawing on multidisciplinary expertise, the agenda integrated data on the preva-
lence and health impact of IPV violence, with an overview of the implementation science framework, and a
panel of innovative IPV screening interventions. Recommendations were generated for developing, testing, and
implementing clinic-based interventions to reduce violence and mitigate its health impact.
Results: The strength of evidence supporting specific IPV screening interventions has improved, but the optimal
implementation and dissemination strategies are not clear. Implementation science, which seeks to close the
evidence to program gap, is a useful framework for improving screening and intervention uptake and ensuring
the translation of research findings into routine practice.
Conclusions: Findings have substantial relevance to the broader research, clinical, and practitioner community.
Our conference proceedings fill a timely gap in knowledge by informing practitioners as they strive to imple-
ment universal IPV screening and guiding researchers as they evaluate the success of implementing IPV in-
terventions to improve women’s health and well-being.
Introduction
Over two decades of foundational research confirmintimate partner violence (IPV) as a significant threat to
women’s health and well-being. The latest national survey
data demonstrate that 28.8% of women report having had a
partner who was physically, sexually, or psychologically
aggressive.1 Compelling evidence exists that physical and
sexual IPV have significant consequences for women’s gen-
eral, reproductive, sexual, and mental health, including
long-term chronic illnesses.1–10 The burden of IPV among
adolescent and adult women, coupled with the estimated $4
1Johns Hopkins Bloomberg School of Public Health, Department of Population Family & Reproductive Health; Women’s and Children’s
Health Policy Center; 2Johns Hopkins Women’s Health Research Group; 3Johns Hopkins Bloomberg School of Public Health, Center for
Injury Research and Policy, Baltimore, Maryland.
4Johns Hopkins Bloomberg School of Public Health, Department of Health Policy and Management, Baltimore, Maryland.
5Kaiser Permanente, Department of Internal Medicine, Richmond, California.
6University of Kentucky College of Public Health, Department of Epidemiology, Lexington, Kentucky.
7Children’s Hospital of Pittsburgh/University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
8Johns Hopkins School of Nursing, Department of Community-Public Health, Baltimore, Maryland.
9University of Maryland School of Medicine, Department of Epidemiology and Public Health and Department of Pediatrics, Baltimore,
Maryland.
10Johns Hopkins School of Medicine, Department of Internal Medicine, Baltimore, Maryland.
11Johns Hopkins Bloomberg School of Public Health, Department of Health, Behavior and Society, Baltimore, Maryland.
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billion spent annually in healthcare services related to IPV,11
illustrate the need for a swift and effective national public
health response.
Routine violence-related screening in the healthcare setting
has been recommended since 1984.12–14 A recent review
concluded that IPV screening can successfully identify sur-
vivors and, in some cases, can reduce abuse and improve
clinical outcomes.15 There is a need to transform promising
interventions for improving women’s health into standard
care. Ensuring the implementation of effective IPV screening
efforts is both important and timely. In 2011, the Institute of
Medicine (IOM) recommended universal IPV screening in
their Clinical Preventive Services for Women consensus re-
port.16 This recommendation was quickly adopted by the U.S.
Department of Health and Human Services, making routine
screening and counseling for IPV a covered preventive health
service for women. Implementing these recommendations
and assuring that they become standard care and reduce vi-
olence against women require careful consideration of the IPV
screening and counseling literature as well as lessons learned
in putting effective interventions into practice.15,17 The po-
tential benefits of IPV screening and counseling are influenced
by their implementation, yet to date, research concerning this
translation process has been lacking (e.g., understanding why
interventions succeed or fail, how to successfully implement
screening and counseling, and how to monitor, identify, and
respond to gaps in this process).
Against this backdrop, we convened a 1-day symposium,
entitled ‘‘Responding to Violence Against Women: Emerging
Evidence, Implementation Science, and Innovative Interven-
tions,’’ at the Johns Hopkins Bloomberg School of Public
Health on May 21, 2012. The agenda featured a presentation
on implementation science to guide our thinking about how
to ensure the effective implementation of IPV screening into
standard practice, followed by a panel of speakers who pre-
sented four approaches to healthcare-based screening. Over
100 practitioners and academics from seven states and the
District of Columbia participated. We summarize the pre-
sentations and dialogue from this event and make the case for
establishing, implementing, and evaluating a large-scale
healthcare-based screening and intervention initiative as one
response to violence against women.
What Can Implementation Science Do for Us?
Shannon Frattaroli, Ph.D., M.P.H.
Implementation is ‘‘the process of putting in place or taking
the steps needed to realize evidence-based interventions.’’18
Implementation research, by extension, is the scientific study of
strategies to realize the integration of evidence-based interven-
tions into policy and practice.18 Implementation science draws
from both behavioral and policy literatures. From a behavioral
science perspective, the Diffusion of Innovations theory offers
an explanation of how people and populations receive, process,
and adopt new ideas and interventions. It posits that interven-
tion uptake occurs only after an individual or group acquires
knowledge, is persuaded to act, makes a decision, and acts on
that decision.19 As applied to IPV screening, assuring that
clinicians (screeners) are aware of the IPV problem, understand
how screening can help their patients who are victims of vio-
lence, and envision a role for themselves in implementing a
screening policy are steps in the implementation process that
are needed to ensure that screening will actually occur. The
policy implementation literature emphasizes complementary,
systems-oriented aspects of the implementation process. For
example, characteristics of the policy itself (e.g., does screening
offer a viable solution to the problem?), the people involved in
implementing (e.g., is the administrative leadership sup-
portive of IPV screening?), and the context (does a system
exist to assist women who screen positive?)20 are key con-
siderations emphasized in the policy implementation liter-
ature. Understanding and addressing these factors can
ensure that IPV screening is well received by implementers
and delivered in a way that will yield the positive outcomes
demonstrated in the literature. Assessing whether and how
an IPV screening intervention is implemented is essential; it
allows evaluators to determine how and why interventions
succeed or fail and provides guidance about how to make
adjustments to increase positive impacts. By considering
implementation processes in addition to impact, evaluators
reduce the risk of drawing conclusions about an intervention
that was poorly implemented or never implemented at all.
Concepts related to implementation science are illustrated
well through an example of an initiative fielded in California
that sought to implement the state’s law prohibiting gun
possession by respondents to domestic violence restraining
orders. To implement and enforce this policy, the initiative
first sought to raise awareness about the law among protected
parties, respondents, law enforcement, and advocates and
then to assure that a system was in place to allow for gun
surrender. In two pilot counties, the research team collected
process and impact data to generate an in-depth under-
standing of how the policy was implemented and enforced.21
Data collection occurred in real time, and evaluators and
implementers communicated regularly so that findings could
inform and refine the intervention.
In both counties, the impact data showed an increase in
guns surrendered, suggesting that the policy was being
translated into practice. However, examination of the process
of implementation identified several opportunities to
strengthen the intervention. In both counties, sheriffs’ detec-
tives staffed the intervention teams. As officers with authority
to enforce criminal law, the detectives were able to use in-
vestigative techniques to follow up on information about re-
spondents’ access to guns. Typically, sheriffs’ deputies within
the civil division oversee restraining order service, and the
scope of their civil authority does not allow them to investi-
gate the individuals involved with the orders they serve. The
intervention teams routinely followed up on information
about respondents possessing guns; this strategy yielded
surrendered guns. In contrast, civil deputies are not autho-
rized to investigate the respondents to the restraining orders
they serve, thus limiting their ability to enforce the gun pro-
hibition. This enforcement challenge and the related recom-
mendation to address it would not have been identified had
the evaluation been limited to measures of impact.
This example offers lessons for implementing IPV screen-
ing in healthcare settings. First, understanding implementers’
perspectives and the systems where IPV screening will be
implemented is essential. California’s gun possession prohi-
bition was law for more than a decade before implementation
action was taken in the two pilot counties. Before the inter-
vention, there was little awareness of the law, no system in
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place to implement it, and no incentive to enforce the prohi-
bition. Second, this example illustrates that implementation
matters with regard to intervention impact. A change in pol-
icy did not precede the increase in surrendered guns from
respondents; what changed was an awareness of the law and
the means to assure the law was being upheld. Evaluations
must include implementation measures to account for the
processes involved in realizing IPV screening. The mere ex-
istence of a policy does not automatically lead to its im-
plementation. In order to translate effective IPV screening
interventions into standard practice, an understanding of the
ways in which IPV screening policies are implemented and
the barriers and facilitators to effective implementation is es-
sential.
Panel of Innovative Interventions:
What Works and Why?
Building from the implementation science framework, four
panelists representing a range of healthcare-based IPV
screening and intervention approaches were asked to briefly
describe each intervention and its premise, provide insight on
why and how it was successful, and reflect on the translation
of the approach into standard practice. To achieve breadth,
we purposefully selected a large-scale systems model and
targeted interventions in family planning (FP), pediatric, and
home-visiting settings.
Using a Systems Model Approach to Improving IPV
Services in a Large Healthcare Organization
Brigid McCaw, M.D., M.P.H., M.S.
Premise
With 9 million members across nine states and the District
of Columbia, Kaiser Permanente (KP) is the largest nonprofit
health plan in the United States. KP’s integrated system of
care includes ambulatory and hospital services, extensive
experience in team-based care and chronic condition man-
agement, and a fully implemented electronic medical record
(EMR). The KP Systems Model is designed to make use of the
entire healthcare environment, facilitate change in clinical
practice by ‘‘making the right thing easier to do,’’ and inte-
grate IPV screening into everyday care.
Intervention
The key components of the Systems Model ensure an ef-
fective clinical response to IPV regardless of where the patient
accesses medical care (Fig. 1). A supportive environment
provides easy access to information and encourages disclo-
sure. Tools in the EMR support clinicians who offer routine
inquiry and referral, asking patients about domestic violence
(DV) in a sensitive manner and knowing how to respond
when a patient discloses abuse. Their role is clear and limited:
ask, affirm, assess, document, and refer. On-site services are
provided by behavioral health clinicians who triage for
mental health needs and begin the safety planning process.
Robust community linkages ensure access to essential DV
crisis and ongoing advocacy support services. At each medi-
cal center, a multidisciplinary team, led by a physician
champion, provides leadership and oversight of systems
model implementation. Quality improvement metrics, in-
cluding IPV identification and referral rates, are communi-
cated quarterly to departments and medical centers.
Findings
Implementation of the KP Systems Model has been asso-
ciated with a 6-fold increase in IPV identification between
2000 and 2011 in KP’s Northern California Region (Fig. 2). The
majority of those identified received mental health follow-up
care. Identification is occurring more often in ambulatory
care rather than in the emergency department, suggesting
that members are being recognized earlier and potentially
before more serious injury occurs. Following this successful
FIG. 1. Systems Model
for intimate partner violence
prevention.
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implementation in all northern California KP medical centers
over the past decade, implementation is now underway in the
other eight KP regions.
Lessons learned
Healthcare organizations can effectively implement IPV
screening and intervention as part of routine healthcare ser-
vices using a comprehensive coordinated Systems Model
approach. Implementation is facilitated by tools that prompt
screening, such as the EMR, a simple and consistent strategy
for clinicians about how to respond to disclosure of IPV, and
patient access to on-site IPV support services. Dissemination
and scaling up are facilitated by a phased work plan, local
teams led by a clinician champion and opportunities to share
best practices, address challenges, and develop consistent
training materials. Regular reporting of quality improvement
indicators and aligning IPV prevention work with major
healthcare initiatives, such as safety, service, and cost, are
essential to gaining executive sponsorship and sustaining the
work over time.
Making the Connection: Partner Violence, Reproductive
Coercion, and Unintended Pregnancy
Elizabeth Miller, M.D., Ph.D.
Premise
IPV is associated with unintended pregnancy,22–27 in part
through compromised sexual decision making and limited
ability to enact contraceptive and condom use.25,28–33 Abusive
partners’ control of women’s reproduction through condom
refusal, pressuring women to get pregnant, and birth control
sabotage is an increasingly recognized phenomenon, defined
as reproductive coercion.34–36 Given these data, a targeted
intervention was developed to integrate IPV screening within
discussion of contraception and reproductive coercion in FP
clinical settings.
Intervention
The Partner Abuse Intervention to Reduce Uninten-
ded Pregnancy (PAIR-UP) was designed collaboratively by
community-based practitioners, advocates, and researchers
for implementation in routine FP clinical settings. The inter-
vention includes (1) an integrated assessment for IPV and
reproductive coercion that provides both screening and edu-
cation, (2) discussion of harm reduction strategies to reduce
risk for unintended pregnancy and IPV, and (3) supported
referrals to IPV support services. Implemented by FP coun-
selors whose role as lay professionals often lends them more
familiarity with patients, the intervention focuses on making
the link among IPV, reproductive coercion, and women’s
health. It is distinct from standard practice or direct screening
in its emphasis on universal education in addition to direct
routine inquiry (We are sharing this information with all our
clients because so many women are affected by unhealthy
relationships that can have serious impact on their health).
The safety card provided to all patients reinforces these con-
cepts and provides information about harm reduction strat-
egies and national hotlines. During intervention training,
providers meet personally with designated advocates at local
support services to enhance the referral system. Finally, the
emphasis on harm reduction and connection of FP clinics with
IPV services underscores that the FP clinic is a safe place for all
women to seek care for unhealthy relationships.
Findings
The pilot evaluation followed women for 4 months and
identified a 71% reduction in pregnancy pressure (a key ele-
ment of reproductive coercion) among women experiencing
recent IPV.37 Women receiving the intervention were also 60%
more likely to end a relationship because it felt unhealthy or
unsafe.37 To build on these findings, a large 24 FP clinic
cluster-randomized controlled trial is underway in Western
Pennsylvania with the goal of enrolling 3600 women and
following women for 12 months to assess intervention effects
on unintended pregnancy and IPV.
Lessons learned
Scaling up the intervention from a small pilot study to
broader implementation has been enhanced through identi-
fying a champion (generally the office manager or lead nurse
practitioner), the use of a safety card as a prompt for routine
FIG. 2. IPV identification
among patients in the
Northern California Region
from 2000 to 2011.
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inquiry with every clinical encounter, and through training of
the entire FP clinic staff. The training provides a rationale
for the intervention, in that clinic staff and providers recog-
nize the immediate impact of abuse on women’s reproductive
decision making and are empowered to offer harm reduction
options and referrals to IPV services. The ease of giving out
the safety card (rather than asking one right question) facili-
tates a conversation about healthy and unhealthy relation-
ships. Additionally, strategically placed IPV information
(posters, local resources) throughout the clinic reinforces the
message to patients that the clinic is a safe place for discussion
of violence and reminds providers that IPV education and
routine inquiry are important. Similar to the KP model, pa-
tients who disclose abuse can receive immediate support.
Clinician comfort in making supported referrals is facilitated
by introducing each site to their local domestic and sexual
violence advocates through formal and informal staff meet-
ings. By building clinician (implementer) comfort with how
they can connect someone who discloses abuse, im-
plementation and sustainability are promoted.
Screening for IPV in Pediatric Settings: Findings
from A Safe Environment for Every Kid (SEEK)
Wendy G. Lane, M.D., M.P.H.
Premise
Child maltreatment (CM) is pervasive; poses large costs to
individuals, families, communities, and society; and is
strongly associated with IPV. Between 30% and 60% of fam-
ilies with child protective service reports for physical abuse
have a history of IPV.38,39 Families with maternal IPV or
forced sexual activity have nearly twice the odds of being
reported to child protective services.40 The pediatric profes-
sion has long recognized the role of the family and home
environment in children’s well-being; IPV screening and in-
tervention may, therefore, be seen as a logical extension of
well child care. Pediatric primary care providers are ideally
suited to address IPV, as most children receive primary
preventive care, particularly in the first few years of life,
and pediatricians generally have positive relationships with
families.
Intervention
The primary goal of the SEEK intervention is to reduce CM
by targeting key associated risk and protective factors, in-
cluding IPV. The intervention consists of training health
providers to screen for CM risk and briefly assess and refer
families to local community resources. It is implemented us-
ing a standardized Parent Screening Questionnaire (PSQ) to
assess IPV and other risk factors; families are provided access
to a social worker. The PSQ instrument assesses IPV through
three validated questions pertaining to physical assault, sex-
ual assault, and fear of partner; items are embedded with less
sensitive topics for participant comfort.
Findings
The evaluation randomized 18 private pediatric practices in
central Maryland, including a total of 101 pediatricians and
pediatric nurse practitioners, to receive either standard care or
the SEEK intervention. Among the 1119 families in the study,
mothers in the intervention group reported fewer instances of
partner-to-mother physical assault at the 6-month and 12-
month follow-up assessments. Findings from the SEEK model
indicate that primary care pediatric practice is a feasible set-
ting for addressing IPV.
Lessons learned
A standardized screening process coupled with training
enables the physician to be comfortable with screening that is
central to the success of this intervention. Timely access to a
social worker for those who screen positive may also enhance
physician comfort, as they have rapid assistance in the case of
a positive screen. Linking IPV screening with CM prevention
and health is an important concept, as pediatric primary care
providers may be more willing to address IPV as part of a CM
prevention program rather than a stand-alone intervention.
Additional issues to be addressed include the availability and
adequacy of services in other settings and if the program
would be equally effective without a social worker. Families
in this study were primarily middle class, suburban, and
white; the SEEK IPV component was somewhat less effective
when evaluated in an inner-city clinic setting. Additional ef-
forts and resources may be needed to address IPV in inner-
city pediatric clinics.
Integrating Violence Screening and Intervention
into Perinatal Home Visiting
Phyllis Sharps, Ph.D., R.N.
Premise
The home visitation model of health promotion outside the
clinical setting lends itself to interventions for such sensitive
topics as IPV through the ongoing relationships and comfort
established with home visiting nurses in the home setting. The
Domestic Violence Enhanced Home Visitation (DOVE) in-
tervention (R01 NR009093 NINR/NIH) was developed to
build on the home visiting model41 to enhance child and
family development and improve health and safety outcomes
through integrated IPV identification, assessment, and pre-
vention. Women are provided with education about the
harmful effects of IPV, connected with support resources,
and, when safe to do so, supported for healthy relationship
promotion with fathers and other men.
Intervention
The DOVE intervention combines a structured IPV em-
powerment intervention with public health nurse perinatal
home visitation. Violence-related screening, assessment, and
education are provided through an interactive approach that
emphasizes support and empathy and respect for women’s
disclosures of abuse. Screening and intervention are guided
by a pamphlet that nurses review with the woman in an in-
teractive manner so the mother or mother-to-be is encouraged
to describe her experiences and choose personal safety op-
tions as they proceed. Nurses provide mothers with infor-
mation about IPV, options in a violent relationship, and child
development and build related skills, such as parenting, ac-
cessing violence support resources, and safety behaviors.
Nurses also provide mothers with decision-making and
problem-solving skills in an effort to enhance women’s sense
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of empowerment. Women receive the intervention over three
prenatal and three postpartum (up to 12 weeks) sessions.
Findings
Evaluation of the DOVE model is currently underway in
rural and urban settings. Qualitative data show that women
whose violence was addressed early during the home visiting
program are making positive choices to improve their lives
and their children’s lives by 24 months postdelivery. Women
have also expressed that talking about the violence with the
home visitor has been powerful. Preliminary findings show a
promising trend of decreased mean scores on self-reported
violence at 12, 18, and 24 months postpartum on two violence
measures: the Conflict Tactics Scale and Severity of Violence
Against Women. Further analyses will consider maternal and
child health outcomes, including growth, development, and
physical health.
Lessons learned
The DOVE intervention leverages the ongoing, supportive
relationships established in the home visiting context for a
safe and interactive IPV screening and intervention process.
By building on the home visitor’s role as a health promoter, it
naturally extends the discussion from perinatal health strat-
egies to violence-related safety and intervention skill build-
ing. Echoing lessons from other interventions, home visitor
comfort in discussing IPV is central to implementation. The
findings underscore the need for IPV-related support and
training for implementing home visiting nurses. Given the
need for training, buy-in from local public health adminis-
trators is central to sustainability of this program. Simulta-
neously evaluating this approach in both rural and urban
settings enables an understanding of its integration into a
broad range of settings and cultural contexts.
Discussion: Synthesis and Recommendations
for Developing, Testing, and Implementing
Healthcare-Based IPV Screening Interventions
In all the interventions presented, universal, in-person
screening was paired with provider training. This combina-
tion supports provider comfort in screening and patient
comfort in responding to screening, thus enabling both the
implementation and positive impact of screening. The KP
model illustrates that provider clarity about how to handle
positive IPV screens empowers clinicians to implement
screening.42 The DOVE and PAIR-UP interventions exemplify
the patient comfort that can be achieved through the use of a
conversational, educational approach that gives women an
opportunity to respond to screening in a safe and supported
environment, link their own health with abuse experiences,
and receive information about support services regardless of
their decision to disclose abuse. All interventions provided
immediate access to services, either on-site in the case of SEEK
and KP or supported referrals in the case of the DOVE and
PAIR-UP. As illustrated by PAIR-UP, introducing clinic staff
to IPV advocates at local support services facilitates provider
familiarity with services and comfort in making referrals.
Findings provide direction to providers seeking to implement
universal screening: a conversational, educational approach,
informed by provider training, with a clearly defined protocol
for referral to support services is recommended to maximize
screening uptake, sustainability, and success. From an im-
plementation science perspective, relevant process outcomes
include provider comfort in screening and clarity in the pro-
cess once a survivor is identified. Programmatically, and as
the IOM screening recommendations are implemented na-
tionally, the efficacy and availability of follow-up interven-
tions must be confirmed before implementing screening.
When considered from the implementation science frame-
work, results of the interventions also speak to the need for and
guide the expansion of screening interventions to a range of
health settings. The SEEK and DOVE studies illustrate the rel-
evance of pediatric clinics and home visiting programs to
identify and support survivors. Providing implementers with a
rationale that is relevant to their specific healthcare setting and
leveraging the links of violence with other negative outcomes,
such as CM and unintended pregnancy, can emphasize the
rationale for screening to implementers. In turn, implementa-
tion and sustainability are strengthened when providers rec-
ognize the value of screening in addressing clinical goals.
As evidenced in several recent trials, screening with mini-
mal service provision is unlikely to influence well-being.43,44
Understanding the integration of screening with the support
services that follow emerged as a central research gap. Short
of the KP model, whose systems approach enables tracking
patients after intervention and referral, little research exists on
what happens for women after a positive screen, yet tracking
this process is central to understanding the impact of screen-
ing, as many harm-reduction and safety enhancement steps
occur outside of the clinical setting. Implementation research
related to service availability, whether or not individuals seek
services and why or why not, is likely to support a clearer
understanding of the true impact of screening. Screening can
be challenging in facilities that do not provide on-site violence
support services but can be achieved through strong com-
munity partnerships. The relative effectiveness of on-site vs.
community resources, what those resources need to include
(e.g., legal, housing, counseling, child care), and who should
provide them also need to be investigated.
The heterogeneity of outcomes assessed in violence-related
trials challenges our ability to comparatively evaluate IPV
screening interventions, echoing conclusions from a recent
review.15 The process of reducing IPV can be lengthy, yet the
limited follow-up periods supported in many trials compro-
mise our ability to evaluate this end point. Both short-term
and long-term outcomes are valuable; measures should be
actionable, clinically meaningful, easily assessed, and facili-
tated if possible by the use of EMRs.17 Consistently assessing
more proximal outcomes, such as contact with IPV support
services and taking active harm reduction steps, will allow an
understanding of women’s trajectories towards the ultimate
goals of safety and improved health. Qualitative research
with patients to clarify their own perspectives on health and
safety can complement quantitative findings to clarify causal
pathways. The implementation science framework can help to
identify and integrate appropriate process and fidelity out-
comes for evaluation research. Adequate funding is necessary
to ensure fidelity when successful interventions are im-
plemented more broadly or in new settings. The iterative
process of intervention implementation across settings, with
refinements and enhancements for specific populations, must
be monitored closely to avoid compromised fidelity.
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Finally, in recognition of the need for a multidisciplinary
approach to prevention, several additional research gaps
were identified, including research on abusers and effective
interventions for them, the role of social context and norms in
abusive behaviors, and the role of other elements of the sup-
port system for women (e.g., housing and employment ser-
vices) and how they may support resilience among women.
Conclusions
Findings from these promising and diverse innovative in-
terventions, coupled with the implementation science frame-
work, provide much needed direction for the implementation
of clinic-based IPV screening interventions and the research
agenda that will ensure their rigorous evaluation. The im-
plementation science framework is one on which we should
rely increasingly as effective pilot interventions are im-
plemented at scale. We recommend multisite, long-term in-
tervention trials that follow women beyond the healthcare
setting to understand their use of support services and sup-
port development of recommendations for (1) short-term and
long-term outcomes that can be harmonized across trials and
(2) process outcomes. Finally, the new preventive services
requirement for IPV screening and counseling provides an
unparalleled opportunity for women’s health researchers and
advocates to come together to find, implement, and dissemi-
nate comprehensive screening and support services to reduce
violence and improve women’s quality of life. Such packages
will have essential elements, such as the screening approaches
described here, but will need to be tailored to the context in
which the services are provided and the population being
served. This is an ambitious agenda, but the proceedings from
this conference offer both insights and optimism for moving
forward and reducing the burden of IPV that threatens
women’s health, safety, and well-being.
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